REFERENCES
- Stamey TA, Yang N, Hay AR, McNeal JE, Freiha FS, Redwine E. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 1987; 317: 909 — 16.
- Partin AW, Carter HB, Chan DW, Epstein JI, Oesterling JE, Rock RC, Weber JP, Walsh PC. Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia. J Urol 1990; 143: 747 — 52.
- Catalona WJ, Smith DS, Ratliff TL, Dodd KM, Coplen DE, Yuan, JJJ, Petros JA, Andriole GL. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med 1991; 324: 1156 — 61.
- Stenman U-H, Leinonen J, Alfthan H, Ranniko S, Tuhkanen K, Alfthan 0. A complex between prostate-specific antigen and alpha 1-antichymo-trypsin is the major form of prostate-specific anti-gen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer. Cancer Res 1991; 51: 222 — 6.
- Lilja H, Cockett AT, Abrahamsson PA. Prostate specific antigen predominantly forms a complex with alpha 1-antichymotrypsin in blood. Implica-tions for procedures to measure prostate specific antigen in serum [review]. Cancer 1992; 70: 230–4.
- Christensson A, Björk T, Nilsson 0, Dahlen U, Matikainen MT, Cockett AT, Abrahamsson PA, Lilja H. Serum prostate specific antigen complexed to alpha 1 — antichymotrypsin as an indicator of prostate cancer. J Urol 1993; 150: 100 — 5.
- Hasenson M, Lundh B, Stege R, Carlström K, Pousette A. PAP and PSA in prostatic carcinoma cell lines and aspiration biopsies: relation to hor-mone sensitivity and to cytological grading. The Prostate 1989; 14: 83–90.
- Stege R, Lundh B, Tribukait B, Pousette A, Carlström K, Hasenson M. Deoxyribonucleic acid ploidy and the direct assay of prostatic acid phophatase and prostate specific antigen in fine needle aspiration biopsies as diagnostic methods in prostatic carcinoma. J Urol 1990; 144: 299— 302.
- Stege R, Tribukait B, Lundh B, Carlström K, Pousette A, Hasenson M. Quantitative estimation of tissue prostate specific antigen, deoxyribonucleic acid ploidy and cytological grade in fine needle aspiration biopsies for prognosis of hormonally treated prostatic carcinoma. J Urol 1992; 148: 833 — 7.
- Harmer MH. TNM classification of malignant tumours, 3rd ed. Geneva: International Union Against Cancer, 1979
- Franzén S, Giertz, G, Zajicek J. Cytological diag-nosis of prostatic tumours by transrectal aspiration biopsy: a preliminary report. Br J Urol 1960; 32: 193 — 6.
- Tribukait B. Flow cytometry in surgical pathology and cytology of tumors of the genito-urinary tract. In: Koss GL, Coleman DV (eds). Advances in Clin-ical Cytology 1984; 2: 163 — 89.
- Peto R, Pike MC, Armitage P. Design and analysis of randomized clinical trials requiring prolonged observation of each patient II analysis and exam-ples. Br J Cancer 1977; 35: 1 — 38.
- Cox DR. Regression models and life tables. J Roy Stat Soc 1972; 34: 187 — 220.